Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DecisionLine Clinical Research was a specialized contract research organization (CRO) based in Toronto, Canada, focusing on early-phase clinical trials. Established in 1997, the company gained international recognition for its expertise in central nervous system (CNS) drug development and human abuse liability (HAL) assessments. DecisionLine operated a state-of-the-art 82-bed clinical pharmacology unit and provided comprehensive services including psychopharmacology, medical writing, and biostatistics. The company was acquired by Kendle International in 2008 to bolster its global early-phase capabilities. Following subsequent mergers, its operations were eventually integrated into Syneos Health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DecisionLine Clinical Research.